Prion protein scrapie and the normal cellular prion protein

被引:41
作者
Atkinson, Caroline J. [1 ]
Zhang, Kai [1 ]
Munn, Alan L. [2 ,3 ]
Wiegmans, Adrian [4 ]
Wei, Ming Q. [1 ]
机构
[1] Griffith Univ, Div Mol & Gene Therapies, Menzies Hlth Inst, Gold Coast, Qld, Australia
[2] Griffith Univ, Menzies Hlth Inst Queensland, Mol Basis Dis Program, Lab Yeast Cell Biol, Gold Coast, Qld, Australia
[3] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia
[4] QIMR Berghofer Med Res Inst, Tumour Microenvironm Lab, Herston, Qld, Australia
基金
澳大利亚研究理事会;
关键词
Creutzfeldt-Jakob disease; bovine spongiform encephalopathy; Alzheimer's disease; infectious protein; prion treatment; PRNP; CREUTZFELDT-JAKOB-DISEASE; DEPRESSIVE-LIKE BEHAVIOR; STRAUSSLER-SCHEINKER-SYNDROME; COPPER-BINDING PROTEIN; COGNITIVE DEFICITS; BLOOD-TRANSFUSION; COLORECTAL-CANCER; ALZHEIMER-DISEASE; MOLECULAR ASPECTS; DENDRITIC CELLS;
D O I
10.1080/19336896.2015.1110293
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prions are infectious proteins and over the past few decades, some prions have become renowned for their causative role in several neurodegenerative diseases in animals and humans. Since their discovery, the mechanisms and mode of transmission and molecular structure of prions have begun to be established. There is, however, still much to be elucidated about prion diseases, including the development of potential therapeutic strategies for treatment. The significance of prion disease is discussed here, including the categories of human and animal prion diseases, disease transmission, disease progression and the development of symptoms and potential future strategies for treatment. Furthermore, the structure and function of the normal cellular prion protein (PrPC) and its importance in not only in prion disease development, but also in diseases such as cancer and Alzheimer's disease will also be discussed.
引用
收藏
页码:63 / 82
页数:20
相关论文
共 154 条
[1]   Prions: Protein Aggregation and Infectious Diseases [J].
Aguzzi, Adriano ;
Calella, Anna Maria .
PHYSIOLOGICAL REVIEWS, 2009, 89 (04) :1105-1152
[2]   Dextran sulfate sodium inhibits amyloid- oligomer binding to cellular prion protein [J].
Aimi, Takahiro ;
Suzuki, Koichiro ;
Hoshino, Tatsuya ;
Mizushima, Tohru .
JOURNAL OF NEUROCHEMISTRY, 2015, 134 (04) :611-617
[3]   Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo [J].
Altmeppen, Hermann C. ;
Prox, Johannes ;
Puig, Berta ;
Kluth, Mark A. ;
Bernreuther, Christian ;
Thurm, Dana ;
Jorissen, Ellen ;
Petrowitz, Bettina ;
Bartsch, Udo ;
De Strooper, Bart ;
Saftig, Paul ;
Glatzel, Markus .
MOLECULAR NEURODEGENERATION, 2011, 6
[4]  
Antonacopoulou AG, 2008, ANTICANCER RES, V28, P1221
[5]   Prion Protein Expression and the M129V Polymorphism of the PRNP Gene in Patients With Colorectal Cancer [J].
Antonacopoulou, Anna G. ;
Palli, Maria ;
Marousi, Stella ;
Dimitrakopoulos, Fotinos-Ioannis ;
Kyriakopoulou, Urania ;
Tsamandas, Athanasios C. ;
Scopa, Chrisoula D. ;
Papavassiliou, Athanasios G. ;
Kalofonos, Haralabos P. .
MOLECULAR CARCINOGENESIS, 2010, 49 (07) :693-699
[6]   Early clinical signs and imaging findings in Gerstmann-Straussler-Scheinker syndrome (Pro102Leu) [J].
Arata, H. ;
Takashima, H. ;
Hirano, R. ;
Tomimitsu, H. ;
Machigashira, K. ;
Izumi, K. ;
Kikuno, M. ;
Ng, A. R. ;
Umehara, F. ;
Arisato, T. ;
Ohkubo, R. ;
Nakabeppu, Y. ;
Nakajo, M. ;
Osame, M. ;
Arimura, K. .
NEUROLOGY, 2006, 66 (11) :1672-1678
[7]   A case of variably protease-sensitive prionopathy treated with doxycyclin [J].
Assar, Hamid ;
Topakian, Raffi ;
Weis, Serge ;
Rahimi, Jasmin ;
Trenkler, Johannes ;
Hoeftberger, Romana ;
Aboulenein-Djamshidian, Fahmy ;
Stroebel, Thomas ;
Budka, Herbert ;
Yull, Helen ;
Head, Mark W. ;
Ironside, James W. ;
Kovacs, Gabor G. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (07) :816-U137
[8]   The normal cellular form of prion protein modulates T cell responses [J].
Bainbridge, J ;
Walker, KB .
IMMUNOLOGY LETTERS, 2005, 96 (01) :147-150
[9]   Evaluation of quinacrine treatment for prion diseases [J].
Barret, A ;
Tagliavini, F ;
Forloni, G ;
Bate, C ;
Salmona, M ;
Colombo, L ;
De Luigi, A ;
Limido, L ;
Suardi, S ;
Rossi, G ;
Auvré, F ;
Adjou, KT ;
Salès, N ;
Williams, A ;
Lasmézas, C ;
Deslys, JP .
JOURNAL OF VIROLOGY, 2003, 77 (15) :8462-8469
[10]   Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice [J].
Beckman, Danielle ;
Santos, Luis E. ;
Americo, Tatiana A. ;
Ledo, Jose H. ;
de Mello, Fernando G. ;
Linden, Rafael .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (33) :20488-20498